Evidence map›Paper›PMID 32461915›Full record

ArticleToxicology reports2020

Antibacterial activity and subchronic toxicity of

Anis Yohana Chaerunisaa, Yasmiwar Susilawati, Muhaimin Muhaimin, Tiana Milanda, Rini Hendriani, Anas Subarnas

Abstract readCase Reports
In one paragraph

Article in Toxicology reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed.

  1. Review
  2. Review
  3. Review
  4. The Potential ofPharmaceuticals (Basel, Switzerland) · 2025
    Article
  5. Review
  6. Review
  7. Article
  8. Toxicology reports · 2020
    Article
  9. Article
  10. Antibacterial Activity of Tris NaCl and PBS Buffer Protein Extract ofDose-response : a publication of International Hormesis Society
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Anis Yohana ChaerunisaaDepartment of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Yasmiwar SusilawatiDepartment of Pharmacy Biology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Muhaimin MuhaiminDepartment of Chemistry, Faculty of Science and Technology, University of Jambi, Jl. Raya Jambi-Muara Bulian Km 15 Mendalo Indah, Jambi 36361, Indonesia.
Tiana MilandaDepartment of Pharmacy Biology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Rini HendrianiDepartment of Pharmacology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.
Anas SubarnasDepartment of Pharmacology, Faculty of Pharmacy, Universitas Padjadjaran, Sumedang 45363, Indonesia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Increasing incidence of antibiotic resistance necessitates the development of more potent antibiotics. The aim of this work was to evaluate the antibacterial activity of

Indexed as

Antibacterial agentCassia fistula L.Salmonella typhosaSubchronic toxicity

Identifiers

PMID32461915
PMCPMC7240208

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.